Five years after legalization, it’s time for a public health strategy on cannabis
Ruth Ross
[In Canada] We have world experts in cannabis research from coast-to-coast, and we are uniquely positioned to have high-quality, well-funded research on its medical use and potential harms. In a global landscape where many jurisdictions are moving toward legalization, we can be leaders in data-driven policy [. . .]
Five years from now, will we be dealing with major public health challenges that could have been avoided? Or will we finally be able to provide patients and people who use cannabis with the knowledge that they need to make evidence-based, informed decisions about their health?
Professor, Department of Pharmacology and Toxicology and Director, Toronto Cannabis and Cannabinoid Research Consortium (TC3)
Published in The Globe and Mail, October 18, 2023.
In September 2023, Ross received the Mechoulam Award for Outstanding Contributions to the Field of Cannabinoid Research from the International Cannabinoid Research Society.